WAO Press Release
For Immediate Release
January 21, 2009
WAO MEETING TO YIELD POSITION STATEMENT ON SUB-LINGUAL IMMUNOTHERAPY
MILWAUKEE -- Delivery of immunotherapy by the sub-lingual (SLIT) route is an exciting therapeutic strategy, gradually being adopted by allergy communities throughout the world. The World Allergy Organization (WAO) will host a meeting in Paris, 22-23 January 2009, to develop the first global Position Statement on SLIT. Both the meeting and the Position Paper are being led by Professor G.W. Canonica, President, WAO, a global umbrella organization serving the needs of allergists and clinical immunologists world-wide.
The meeting aims to:
- Develop and propose a state-of-the-art review on SLIT based on the findings from the meetings
- Prepare guidelines for SLIT based on the World Health Organization (WHO) model of recommendations
- Develop practice parameters
- Define unmet needs as identified in the analysis of recent and ongoing SLIT clinical trials; further studies will be needed to accomplish this task
- Make recommendations for the methodology of future SLIT clinical trials worldwide
To fulfill the envisioned global scope of the meeting, WAO has invited its Regional, National and Affiliate Member Societies to participate by sending representatives. In addition, NGOs, such as Allergic Rhinitis and Its Impact on Asthma (ARIA), European Federation of Allergy and Airway Diseases Patients Association (EFA), International Primary Care Respiratory Group (IPCRG), World Organization of Family Doctors (WONCA), Global Allergy and Asthma European Network (GA2LEN), and the National Institutes of Health (NIH), have also been invited to send no more than two representatives to serve as delegates to the meeting.
About Professor G.W. Canonica
G. Walter Canonica, MD, FAAAAI, is professor and chairman of Allergy and Respiratory Diseases at the Department of Internal Medicine, Genoa University, Italy. Canonica is an internationally renowned expert on immunotherapy and allergic respiratory diseases and has authored over 350 full papers in international journals. His main research interests encompass investigation of different subsets of T lymphocytes and their functional role in basic and clinical research (allergy, organ specific autoimmunity, CNS degenerative diseases and cancer); molecular events and interactions between immunocompetent cells, inflammatory cells, epithelial cells in allergic inflammation and airways remodeling; new antiallergic drugs and new strategies in the treatment of allergic disease; and clinical and immunopharmacological activities of biological response modifiers such as cytokines, monoclonal antibodies, allergen specific immunotherapy and corticosteroids.
About the World Allergy Organization
The World Allergy Organization (WAO) is an international federation whose members consist of 77 regional and national allergology and clinical immunology societies from around the world. By collaborating with member societies, WAO provides direct educational outreach programs, symposia and lectureships to members in 92 countries.
The organization was founded in 1951 and has successfully organized 19 major congresses. WAO also sponsors scientific symposia in developing areas throughout the world and jointly sponsors postgraduate programs on allergy and clinical immunology during professional, non-allergy association congresses. Additional information can be found at http://www.worldallergy.org